Autoimmune pancreatitis
Board exam relevance: in 1 of more than 100 exam reports · rank 181- Synonyms
- AIP, IgG4-related pancreatitis, IgG4-related disease, lymphoplasmacytic sclerosing pancreatitis, idiopathic duct-centric pancreatitis
- Specialty
- Internal medicine · Gastroenterology
- Images
- CT 1 · MRI 1
- Last updated
- 10/2026 · Dr. Pascal Bafteh
Contents
Images (2)
CT
MRIDefinition
Autoimmune pancreatitis (AIP) is a rare, specific form of chronic benign pancreatic disease. Typical features are obstructive jaundice with or without a pancreatic mass and, histologically, a characteristic lymphoplasmacytic infiltrate with fibrosis. The enlarged or focally altered pancreas can mimic pancreatic ductal adenocarcinoma.
Classification
- Type 1 (AIP-1), lymphoplasmacytic sclerosing pancreatitis: pancreatic manifestation of IgG4-related disease, a rare, immune-mediated, systemic fibro-inflammatory multi-organ disease
- Type 2 (AIP-2), idiopathic duct-centric pancreatitis: limited to the pancreas, with granulocytic epithelial lesions; frequently associated with inflammatory bowel disease, especially ulcerative colitis
- Type 3 (AIP-3): iatrogenic, mostly asymptomatic pancreatic injury in patients with advanced malignancies receiving cancer immune drugs that release the body's immune brakes, typically 4–6 months after the start; without pathognomonic histology, usually seronegative
Morphologically, diffuse and focal (mass-forming) forms are distinguished.
Occurrence & epidemiology
Data on frequency are limited. AIP-1 is the most common form and is more frequent in Asia than in the United States and Europe. In a Japanese nationwide survey (2016), incidence was 1–3 and prevalence about 10 per 100,000 adults; the male-to-female ratio was about 3:1 and the mean age at diagnosis 64.8 years. AIP-2 is more common in Western countries than in Asia and affects younger people (on average around 40 years) without sex difference and frequently occurs together with inflammatory bowel disease. AIP-3 accounts for 0.6–4% of immune-mediated adverse events of these cancer immune drugs.
Aetiopathogenesis
The pathogenesis of AIP-1 is unclear; genetic and environmental factors interact. HLA-DRB1 variants, toll-like receptors of the innate immune system and plasmacytoid dendritic cells producing type I interferon and interleukin-33 are involved. This mainly activates Th2 cells and regulatory T cells, whose cytokines (IL-4, IL-10) promote class switching to IgG4. Molecular mimicry with exogenous antigens and a role of the gut microbiota are also discussed.
In AIP-2, Th17 cells infiltrate the periductal tissue and release IL-17, IL-21, IL-22 and IL-23; IL-8 attracts neutrophils, which form the typical granulocytic epithelial lesions. AIP-3 is based on a non-specific, mainly CD8-mediated T-cell response.
Clinical features
AIP-1: mostly older men, predominantly painless.
- obstructive jaundice in about 75%, due to narrowing of the bile duct by the swollen pancreatic head or infiltration of the bile duct wall
- abdominal symptoms in about 40% (mild pain, malaise), less often acute pancreatitis
- loss of body weight, exocrine and endocrine insufficiency with diabetes mellitus
- other organs: IgG4-related cholangitis (together with AIP-1 in about 80%), retroperitoneal fibrosis, inflammation of salivary and lacrimal glands (Mikulicz disease), Riedel thyroiditis, lymphadenopathy, involvement of the aorta, kidneys and lungs; isolated pancreatic involvement is found in about half
AIP-2: more often abdominal pain and acute pancreatitis (in about 50%), as well as painless jaundice, masses and ductal strictures; signs of the associated bowel disease.
Histology
- AIP-1/IgG4-related disease: lymphoplasmacytic infiltrates rich in IgG4-positive plasma cells (in biopsies more than 10 per high-power field), storiform fibrosis and obliterative phlebitis
- AIP-2: fibro-inflammatory infiltration of medium and small pancreatic ducts and acini with pathognomonic granulocytic epithelial lesions composed mainly of neutrophils
- AIP-3: no pathognomonic changes
Diagnosis
- Serology: in AIP-1, serum IgG4 is elevated in about half (ratio of IgG4 to IgG typically above 10%); a normal IgG4 does not exclude the disease, and only about 10% of people with elevated IgG4 have IgG4-related disease. In AIP-2, IgG4 is usually normal, and p-ANCA and c-ANCA are often positive
- Contrast-enhanced CT and MRI: sausage-like, focal or diffuse swelling with straight margins, rectangular tail ("cut-tail"), loss of lobular structure; reduced enhancement in the arterial phase and increasing enhancement in delayed phases; hypodense capsule-like rim; imaging does not reliably distinguish the types
- MRCP: multiple long strictures of the main pancreatic duct without upstream dilatation, prominent side branches; in the mass-forming type the duct passes through the mass
- FDG PET-CT: usually diffuse uptake, often with uptake in salivary glands, prostate and lymph nodes
- Endoscopic ultrasound with fine-needle biopsy: tissue sampling to confirm the diagnosis and distinguish it from pancreatic cancer
Treatment principles
- Before treatment, pancreatic cancer must be carefully excluded, as the two conditions can look similar clinically and on imaging.
- Glucocorticoids are highly effective in both types, and a rapid response also supports the diagnosis.
- In the IgG4-related form (type 1), relapses are common, so maintenance therapy or steroid-sparing immunosuppressants or anti-CD20 antibodies are used; biliary strictures are managed endoscopically if needed, and exocrine or endocrine insufficiency is treated.
Specific treatment regimens with drugs and doses are covered in the InnereFuchs app.
Keep learning in the app
Further reading (open access)
Cross-references
More topics: Gastroenterology
- Ulcerative colitis
- Gastritis (type A, B and C)
- Peptic ulcer disease
- Crohn's disease
- Barrett's esophagus
- Boerhaave and Mallory-Weiss syndrome
- Cholangiocarcinoma (bile duct cancer)
- Choledocholithiasis and acute cholangitis
- Gallstones and acute cholecystitis
- Chronic pancreatitis
- Clostridioides difficile infection
- Diverticular disease and diverticulitis
Keep learning
Keep learning with flashcards, exam questions and spot diagnoses in the InnereFuchs app – free, in your browser or as an app.
Related pages: Ulcerative colitis · Gastritis (type A, B and C) · Peptic ulcer disease
Note: Learning content for medical education – not a treatment recommendation and no substitute for diagnosis or treatment decisions in individual cases. Treatment and management are deliberately not covered on this page.